[ad_1]
KATY, TX / ACCESSWIRE / September 13, 2021 / Neutra Corp. subsidiary VIVIS has signed a groundbreaking letter of intent (LOI) with a Houston medical analysis firm that, if it involves a profitable conclusion, would result in testing hemp-based cannabinoids to deal with COVID-19.
Below the LOI’s provisions, VIVIS will now decide the feasibility of working with Mercury Medical Analysis to start out section 1 medical trial on CBD efficacies in combating SARS-COVID-2. The trials might additionally examine further makes use of for anti-inflammation, anti-insomnia, urge for food suppressant and stimulant (CBG vs. CBN), restoration, pain-management, anti-anxiety, and different well being associated prognosis deemed notable for medical trials.
“We’re about to embark on one thing that might have an amazing influence worldwide,” stated Neutra CEO Sydney Jim. “If we in the end determine to pursue this medical analysis, it will simply be one of many largest and extra necessary issues we have achieved. Proper now, COVID has the world in its grip. It is had a far-reaching adverse impact on not solely folks’s well being however has additionally taken a horrible toll on the worldwide economic system. We’ll be taking a look at whether or not hemp-based CBD like that VIVIS produces might assist reverse that.”
There has already been some examine into the topic. A gaggle of medical researchers recently reported that “cannabidiol has potential to forestall and inhibit SARS-CoV-2 an infection.” The researchers’ summary states that human sufferers beforehand taking CBD had “considerably decrease SARS-CoV-2 an infection incidence” when in comparison with the final inhabitants. Click here for more information with this study
Practically 4.6 million people worldwide have died from COVID-19 as of Sep. 7, 2021. Greater than 664,000 of these fatalities have been within the U.S. Virtually two-thirds of Americans (206 million) have gotten no less than one vaccination dose. Nonetheless, new variations of the coronavirus have appeared, threatening progress in combating the sickness and resulting in new infections.
About Neutra Corp.
Neutra Corp. (OTC PINK:NTRR) is an early-stage analysis and improvement firm with a give attention to bringing fashionable wholesome residing options to a multibillion-dollar market. Reducing-edge applied sciences inside the nutraceuticals, meals, and drug, and environmental purification sectors are creating a brand new type of world culture-one the place wherein shoppers are demanding entry to merchandise that promote well being and stave off potential well being risks. One of many nutraceutical sub-markets is the brand new thriving hemp-based CBD market, wherein the Firm intends to take part. For extra info, go to the Firm’s web site at http://www.NeutraInc.com.
NOTICE REGARDING FORWARD-LOOKING STATEMENTS
Protected Harbor Assertion beneath the Personal Securities Litigation Reform Act of 1995: This information launch comprises forward-looking info inside the that means of Part 27A of the Securities Act of 1933, as amended, and Part 21E of the Securities Trade Act of 1934, as amended, together with statements that embody the phrases ‘believes,’ ‘expects,’ ‘anticipate’ or related expressions. Such forward-looking statements contain recognized and unknown dangers, uncertainties, and different components which will trigger the precise outcomes, efficiency, or achievements of the corporate to vary materially from these expressed or implied by such forward-looking statements.
Neutra Contact:
Sydney Jim
888-433-4033
[email protected]
SOURCE: Neutra Corp
View supply model on accesswire.com:
https://www.accesswire.com/663687/Latest-VIVIS-LOI-Potential-First-Step-to-Phase-1-Clinical-Trial-on-Preventing-COVID-19-Infections-Using-CBD
[ad_2]
Source link
